View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Atezolizumab 840 / Bevazicumab 10 / Paclitaxel 90, Breast Cancer
Protocol-ID: 3050 V1.0 (Mini), ATEZ840/BEVA10/PACL90, Breast CaIndication(s)
- Breast Cancer; ICD-10 C50.-
tripel negative
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 12.11.2025